Veracyte (VCYT) Current Assets (2012 - 2026)

Veracyte has reported Current Assets for 15 years, with the latest figure at $574.8 million in Q2 2026.

• Current Assets for Q2 2026 came in at $574.8 million, up 38.61% year-over-year; the trailing twelve-month figure through Jun 2026 was $574.8 million (up 38.61% YoY), and the FY2025 annual result was $488.4 million, up 31.19% from the prior year.
• Current Assets grew to $574.8 million in Q2 2026, from $522.2 million in the prior quarter.
• Over five years, Current Assets peaked at $574.8 million in Q2 2026 and troughed at $235.0 million in Q2 2022.
• A 5-year average of $344.5 million and a median of $305.8 million in 2024 frame the typical range for Current Assets.
• The widest annual swing landed in 2022, when Current Assets plunged 36.7%; it then soared 38.61% in 2026.
• A 5-year view of Current Assets shows it stood at $248.6 million in 2022, then rose by 14.88% to $285.6 million in 2023, then jumped by 30.34% to $372.3 million in 2024, then soared by 31.19% to $488.4 million in 2025, then grew by 17.69% to $574.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $574.8 million in Q2 2026, $522.2 million in Q1 2026, and $488.4 million in Q4 2025.